
Millions of Americans with certain personality trait need extra 'protection' from ultra-processed foods... are YOU one of them?
They are born with what scientists call a strong food reward drive, an intense biological pull toward eating that makes them feel hungrier, eat faster, and struggle to feel full. Their brains are wired to seek out food more aggressively.
While children with this drive can regulate their eating with whole foods, such as fruits, vegetables, and lean proteins, ultra-processed foods, which are packed with refined sugars, industrial fats, and artificial additives, can overwhelm their brain's natural satiety signals.
These foods are designed to bypass fullness cues. Sugary or salty snacks trigger a rush of dopamine in the brain far more robust than apples or grilled chicken.
This dopamine rush causes the brain to seek out those same good feelings over and over again, often in the form of reaching for junk foods over whole produce and lean protein.
Having a strong food reward drive causes a person to crave food constantly, even when they're not hungry, and struggle to stop eating when they're full.
Scientists recommend avoiding ultra-processed foods in the grocery store altogether and reserving them for special occasions. Keeping them in the house while trying to moderate a child's eating habits rarely works, and not keeping them in the home is typically more successful, they said.
It is estimated that Americans obtain roughly 70 percent of their daily calories from ultra-processed foods and a growing body of research has linked a diet full of them increases a person's risk of chronic diseases including diabetes and cancer.
People who score highest on the Reward-based Eating Drive (RED) scale, a self-reported test on lack of satiety and a struggle to stop eating, are more likely to have a high BMI, obesity, and weight fluctuations.
Ultra-palatable foods activate the brain's opioid and dopamine systems. The dopamine rush keeps people coming back for more, while the opioid effect dulls feelings of fullness, stimulates endorphins, and increases cravings.
Research has shown that children with a strong food reward drive can regulate how much whole produce and lean protein they eat, but struggle doing the same with ultra-processed foods.
Research has suggested that some people are genetically predisposed to having fewer dopamine receptors, requring more junk food to attain the same flood of dopamine that hooks people.
Genetics don't solely influence eating behavior, though. If a child is frequently rewarded with junk food or it's constantly available, they are more likely to develop dopamine-driven habits.
But Parents have a significant influence on their children's eating habits.
One study found that around 21 percent of parents used food as a reward, which is associated with emotional overeating in their children.
Kerri Boutelle, a professor of psychiatry and pediatrics at the University of California, San Diego's School of Medicine, works with children struggling with their weight and overeating.
Her years of research have shown that children, even siblings, show different responses to ultra-processed foods.
'One child would eat half of the ice cream cone and put it down,' she told NPR. They have a low food reward drive, meaning that ultra-processed foods do not significantly alter their behavior.
'They just eat to get full, and then they move on,' Boutelle said.
The other child, who has a high food reward drive, would gobble up their ice cream cone and finish the other child's too.
'They want to eat all the time, and it doesn't matter if they're full,' Boutelle added.
'Those kids are going to gain weight in today's environment. I always tell parents, the environment today tricks kids into overeating.'
Reward-based eating is similar to but different from food addiction, which causes obsessive thoughts about food, a loss of control when eating, and continued overeating despite existing health problems, such as obesity or diabetes.
Around 20 percent of American children, more than 14 million, are obese. Roughly 300,000 of them have type 1 or type 2 diabetes.
Boutelle recommends that parents avoid buying ultra-processed foods altogether, but if they do, limit their purchases to three items, as having a wide variety can increase the risk of overeating.
'What you can do as a parent is make your home as safe as it can be for your children,' she said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
12 minutes ago
- Reuters
Hims and Hers beats quarterly profit on steady subscription growth
NEW YORK, Aug 4 (Reuters) - Hims and Hers Health (HIMS.N), opens new tab beat Wall Street estimates for second-quarter profit on Monday, aided by continued subscription growth and surging volume in the telehealth company's weight-loss business. The company reported a quarterly profit of 17 cents per share, higher than the average analyst estimate of 15 cents, according to LSEG data. However, shares fell about 10% in extended trading as quarterly revenue of $544.8 million missed analysts' average expectation of $551.6 million.


Reuters
13 minutes ago
- Reuters
Vertex to stop developing new painkiller as solo treatment after mid-stage study setback
Aug 4 (Reuters) - Vertex Pharmaceuticals (VRTX.O), opens new tab said on Monday it will not continue development of its experimental non-opioid painkiller as a solo treatment after it failed to meet the main goal of a mid-stage trial. The next-generation drug, called VX-993, was found to be generally safe when tested in patients who had a bunion surgery, with most side effects being mild to moderate and no serious problems linked to the painkiller, the company said. Wall Street analysts and investors have been eagerly awaiting the results of this trial that would help Vertex expand beyond its non-opioid Journavx, bolstering its pain drug treatments.


Daily Mail
14 minutes ago
- Daily Mail
Study: Reason behind increase in colon cancer among young people
Advertisement Colon cancer incidence rates in the US surged by almost 50 percent in a year, a new study has revealed. An investigation by the American Cancer Society (ACS) found that after a stable 15-year trend, diagnoses of local-stage colorectal cancer (CRC) rose dramatically in adults aged 45 to 49 years old between 2019 and 2022 in the US. From 2021 to 2022, there was a 50 percent relative increase in diagnoses from 11.7 to 17.5 cases per 100,000 people. Local or early stage indicates the cancer is confined to the original site where it started, has not spread to other areas of the body and usually has no symptoms. If colon cancer is detected and treated in its early stages, the five-year survival rate is approximately 90 percent, while it is around 60 percent if it is diagnosed in its advanced stages. The cost of treatment also dramatically increases, with early-stage colon cancer costing around $40,000 to treat, while advanced stages can exceed $300,000. The study's lead author Elizabeth Schafer put the rise in early-stage colon cancer cases down to recommendations for younger average-risk adults to begin testing for earlier. While the disease is known to be linked to obesity, experts have noted that the disease also seems to also be occurring in fit and healthy patients. Some experts believe the explanation must lie in environmental factors young people have been exposed to more than previous generations. While no 'smoking gun' has been found, there are multiple theories. These include modern chemicals in diets, microplastics, pollution, and one recent study even pinned the surge on exposure to E. coli in food . The recommended age to begin CRC screening was lowered from 50 to 45 years by ACS in 2018 and the United States Preventive Services Task Force (USPSTF) followed suit in 2021. The US already has a lower colon cancer screening age than some other Western nations, including Canada — where it is set at 50 years — and England — which lowered the age from 60 to 50 years in 2021. Early onset colorectal cancer has become the leading cause of cancer-related deaths for men under 50 and the second-leading cause for women under 50 in the US. Over 50,000 Americans are expected to die from colorectal cancer this year, while 150,000 are predicted to be diagnosed with the disease. For the recent ACS study, published Monday in the Journal of the American Medical Association (JAMA) , researchers analyzed CRC cases diagnosed from 2004 to 2022 among adults 20 to 54 years old in the 21 geographic areas of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program. Cases were sorted by age, where the cancer was located, and stage at diagnosis. Results showed that CRC incidence increased steadily by 1.6 percent annually since 2004 among adults 20 to 39 years old and by two percent to 2.6 percent per year since 2012 among adults 40 to 44 and 50 to 54 years old. However, in people 45 to 49 years old, an increase of one percent annually during 2004 to 2019 accelerated to 12 percent per year from 2019 to 2022. This steep increase was driven by the detection of early, local-stage tumors, which increased from 2019 to 2022 by 19 percent per year for colon cancer after previously stable rates and by 25 percent per year for rectal cancer after declining rates. Advanced-stage disease has continued to increase steeply over the past two decades. Incidence of advanced CRC increased from 1.7 to 2.9 percent annually since 2004 among adults under 45 years old and even more rapidly during the past decade in ages 45 to 54. In support of these findings, another ACS led study also published today in JAMA reports that CRC screening among US adults 45 to 49 years of age increased by 62 percent from 2019 to 2023. 'It's not only thrilling to see the increase in colorectal cancer screening among younger adults, but also how it likely ties into rises in earlier stage diagnosis as noted in the other ACS led paper,' said lead author Jessica Star, an associate scientist of cancer risk factors and screening surveillance research at the ACS. 'However, we still have a long way to go. Screening for colorectal cancer in ages 45-49 remains suboptimal and has not increased equitably by both educational attainment and insurance status.' For this study, scientists analyzed the data of more than 50,000 individuals from the National Health Interview Survey, comparing changes in CRC screening from 2019 to 2023 within age groups 40 to 44; 45 to 49; 50 to 54; 55 to 64; and 65 to 75 years old. The data were adjusted for age, sex, race/ethnicity, education, and region. The researchers found up-to-date CRC screening was up 20 percent in 2021 and 37 percent in 2023. The study results showed that among 45- to 49-year-olds, colonoscopy screening increased by 43 percent and stool-based testing increased more than five-fold from 2019 to 2023. Screening increased significantly from 2019 to 2023 in every racial and ethnic group, but remained unchanged among individuals with less than a high school education and those who were uninsured. 'These studies further demonstrate the importance of people having access to comprehensive health insurance, which covers evidence-based preventive services,' said Lisa A. Lacasse, president of ACS's advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). 'With more than 2 million people in America expected to be diagnosed with cancer in 2025, it's more important than ever to make sure that everyone can access necessary screenings. 'ACS CAN will continue to advocate at the state and federal level to expand access for all because it isn't just good policy, it's lifesaving.'